“Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.”

Carter, 2014, Approaching the patient with an anterior mediastinal mass: a guide for radiologists, J Thorac Oncol, 9, S110, 10.1097/JTO.0000000000000295 Carter, 2017, ITMIG Classification of Mediastinal Compartments and Multidisciplinary Approach to Mediastinal Masses, Radiographics, 37, 413, 10.1148/rg.2017160095 Marx, 2014, ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting, J Thorac Oncol, 9, 596, 10.1097/JTO.0000000000000154 Marx, 2015, The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes, J Thorac Oncol, 10, 1383, 10.1097/JTO.0000000000000654 Girard, 2015, Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 26, v40, 10.1093/annonc/mdv277 Zhu, 2004, Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients, Int J Radiat Oncol Biol Phys, 60, 1113, 10.1016/j.ijrobp.2004.05.013 Bott MJ, Wang H, Travis W, Riely GJ, Bains M, Downey R, et al. Management and outcomes of relapse after treatment for thymoma and thymic carcinoma. Ann Thorac Surg 2011;92:1984–91; discussion 1991-1992. Doi: 10.1016/j.athoracsur.2011.07.078. Huang, 2008, Multimodality therapy for locally advanced thymomas: state of the art or investigational therapy?, Ann Thorac Surg, 85, 365, 10.1016/j.athoracsur.2007.10.098 Blumberg, 1995, Thymoma: a multivariate analysis of factors predicting survival, Ann Thorac Surg, 60, 908, 10.1016/0003-4975(95)00669-C Wright, 2008, Management of thymomas, Crit Rev Oncol Hematol, 65, 109, 10.1016/j.critrevonc.2007.04.005 Wright, 2005, Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size, J Thorac Cardiovasc Surg, 130, 1413, 10.1016/j.jtcvs.2005.07.026 Rimner, 2016, Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma-An Analysis of the International Thymic Malignancies Interest Group Retrospective Database, J Thorac Oncol, 11, 1785, 10.1016/j.jtho.2016.06.011 Akaogi, 1996, Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels, J Surg Oncol, 63, 17, 10.1002/(SICI)1096-9098(199609)63:1<17::AID-JSO4>3.0.CO;2-T Gao, 2013, Outcome of multimodality treatment for 188 cases of type B3 thymoma, J Thorac Oncol, 8, 1329, 10.1097/JTO.0b013e31829ceb50 Rimner, 2014, Failure patterns relative to radiation treatment fields for stage II-IV thymoma, J Thorac Oncol, 9, 403, 10.1097/JTO.0000000000000099 A B, A S, M P, P B, N.g L, E D, et al. The role of postoperative radiotherapy for thymomas: A multicentric retrospective evaluation from three Italian centers and review of the literature. J Thorac Dis 7518. J M, X S, L H, Z X, M Y, S Z, et al. Postoperative radiotherapy and tumor recurrence after complete resection of stage II /III thymic tumor: A meta-analysis of cohort studies. OncoTargets and Therapy 4517. ] F Y, J F, Y W, L T, P Z, Y H, et al. The role of postoperative radiotherapy for stage I/II/III thymic tumor-Results of the ChART retrospective database. J Thorac Dis; 2016. Tateishi, 2021, Postoperative Radiotherapy for Completely Resected Masaoka/Masaoka-Koga Stage II/III Thymoma Improves Overall Survival: An Updated Meta-Analysis of 4746 Patients, J Thorac Oncol, 16, 677, 10.1016/j.jtho.2020.12.023 Cowen, 1995, Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer, Radiother Oncol, 34, 9, 10.1016/0167-8140(94)01493-M Takeda, 2004, Thymic carcinoma. Clinical institutional experience with 15 patients, Eur J Cardiothorac Surg, 26, 401, 10.1016/j.ejcts.2004.03.043 Nonaka, 2004, The role of radiotherapy for thymic carcinoma, Jpn J Clin Oncol, 34, 722, 10.1093/jjco/hyh141 Gomez, 2010, Technical advances of radiation therapy for thymic malignancies, J Thorac Oncol, 5, S336, 10.1097/JTO.0b013e3181f20ea2 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, W64 McHugh, 2012, Interrater reliability: the kappa statistic, Biochem Med (Zagreb), 22, 276, 10.11613/BM.2012.031 VonVille HM. Excel workbooks for systematic reviews. 2015, 2015. VonVille HM. Excel workbooks for systematic reviews. University of Texas Health Science Center at Houston School of Public Health…; 2015. Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol, 25, 603, 10.1007/s10654-010-9491-z Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 2020:l6890. Doi: 10.1136/bmj.l6890. Suk Park, 2004, Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification, Ann Thorac Surg, 78, 992, 10.1016/j.athoracsur.2004.03.097 Kondo, 2005, Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan, Ann Thorac Surg, 79, 219, 10.1016/j.athoracsur.2004.06.090 D'Angelillo, 2008, Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection, Int J Radiat Oncol Biol Phys, 71, 420, 10.1016/j.ijrobp.2007.10.006 Regnard, 1996, Prognostic factors and long-term results after thymoma resection: a series of 307 patients, J Thorac Cardiovasc Surg, 112, 376, 10.1016/S0022-5223(96)70265-9 Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Fan, 2020, Intensity Modulated Radiation Therapy Plus Etoposide/Cisplatin for Patients With Limited Advanced Unresectable Thymic Epithelial Tumors: A Prospective Phase 2 Study, Int J Radiat Oncol Biol Phys, 107, 98, 10.1016/j.ijrobp.2019.12.045 Chen, 2010, Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection, Int J Radiat Oncol Biol Phys, 78, 1400, 10.1016/j.ijrobp.2009.09.066 Fan, 2013, Postoperative radiotherapy for completely resected Masaoka stage III thymoma: a retrospective study of 65 cases from a single institution, Radiat Oncol, 8, 10.1186/1748-717X-8-199 Fan, 2020, Impact of Definitive Radiotherapy and Surgical Debulking on Treatment Outcome and Prognosis for Locally Advanced Masaoka-Koga stage III Thymoma, Sci Rep, 10 A.j Y, S.h C, H.k B, H.j K, C.g L, J C. The role of salvage radiotherapy in recurrent thymoma. Radiat Oncol J; 2019. Hao, 2017, Prospective Study of Stereotactic Body Radiation Therapy for Thymoma and Thymic Carcinoma: Therapeutic Effect and Toxicity Assessment, Sci Rep, 7, 13549, 10.1038/s41598-017-12909-z Zhou, 2016, The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis, Ann Thorac Surg, 101, 305, 10.1016/j.athoracsur.2015.06.034 Liao, 2018, The role of postoperative radiation therapy for completely resected stage III thymoma and effect of higher heart radiation dose on risk of cardiovascular disease: A retrospective cohort study, Int J Surg, 53, 345, 10.1016/j.ijsu.2018.04.018 Banfill, 2021, Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions, J Thorac Oncol, 16, 216, 10.1016/j.jtho.2020.11.002 Darby, 2013, Risk of ischemic heart disease in women after radiotherapy for breast cancer, N Engl J Med, 368, 987, 10.1056/NEJMoa1209825 Fernandes, 2010, The role of radiation therapy in malignant thymoma: a Surveillance, Epidemiology, and End Results database analysis, J Thorac Oncol, 5, 1454, 10.1097/JTO.0b013e3181e8f345 Barsky, 2020, Proton-Beam Therapy: At the Heart of Cardiac Dose-Sparing in Mediastinal Radiotherapy for Thymic Carcinoma, J Thorac Oncol, 15, 1240, 10.1016/j.jtho.2020.03.034 Figura, 2013, Postoperative proton therapy in the management of stage III thymoma, J Thorac Oncol, 8, e38, 10.1097/JTO.0b013e31827a8911 Franceschini, 2020, Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma, J Cancer Res Clin Oncol, 146, 2267, 10.1007/s00432-020-03281-z Haefner, 2018, Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma, Acta Oncol, 57, 1713, 10.1080/0284186X.2018.1502467 J.h V, A.t B, T.t P, L.p W, P.e G, S K, et al. Proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma. J Thora Dis; 2015. Mercado, 2019, Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries, Acta Oncol, 58, 1036, 10.1080/0284186X.2019.1575981 Vogel, 2017, Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies, Acta Oncol, 56, 1060, 10.1080/0284186X.2017.1302097 Vogel, 2016, Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: Early response and toxicity assessment, Radiother Oncol, 118, 504, 10.1016/j.radonc.2016.02.003 Ried, 2018, Comparison of the Masaoka-Koga Classification with the New TNM Staging of the IASLC/ITMIG for Thymoma and Thymic Carcinoma, Zentralbl Chir, 143, S44 Marcuse, 2021, Optimal delineation of the clinical target volume for thymomas in the post-resection setting: A multi-center study, Radiother Oncol, 165, 8, 10.1016/j.radonc.2021.10.007 Modh, 2016, Treatment Modalities and Outcomes in Patients With Advanced Invasive Thymoma or Thymic Carcinoma: A Retrospective Multicenter Study, Am J Clin Oncol, 39, 120, 10.1097/COC.0000000000000024 Lu, 2018, Value of Adjuvant Radiotherapy for Thymoma with Myasthenia Gravis after Extended Thymectomy, Chin Med J (Engl), 131, 927, 10.4103/0366-6999.229894 Austin, 2011, An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies, Multivariate Behav Res, 46, 399, 10.1080/00273171.2011.568786 Leuzzi, 2016, Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database, J Thorac Cardiovasc Surg, 151, 47, 10.1016/j.jtcvs.2015.08.034 Soni, 2019, Comparison of Population-Based Observational Studies With Randomized Trials in Oncology, J Clin Oncol, 37, 1209, 10.1200/JCO.18.01074 Lim, 2015, Role of Postoperative Radiotherapy in Nonlocalized Thymoma: Propensity-Matched Analysis of Surveillance, Epidemiology, and End Results Database, J Thorac Oncol, 10, 1357, 10.1097/JTO.0000000000000619 Mou, 2018, Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988–2013), Int J Radiat Biol, 94, 495, 10.1080/09553002.2018.1454618 J.-H F, Q.-W L, F Y, W.-T F, K.n C, Z.-T Y, et al. The role of postoperative radiotherapy for stage I/II/III thymic tumor-results of chart database. J Thora Dis; 2015. F W, L P, J F, Y W, L T, P Z, et al. Postoperative survival for patients with thymoma complicating myasthenia gravis-Preliminary retrospective results of the ChART database. J Thorac Dis; 2016. Intergroupe Francophone de Cancerologie Thoracique. French National Observatory of Patients With Thymic Epithelial Tumor. clinicaltrials.gov; 2020. Shanghai Cancer Hospital, China. Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors. clinicaltrials.gov; 2020.